Literature DB >> 11223249

Identification and characterization of the gene encoding human cytoplasmic polyadenylation element binding protein.

J F Welk1, A Charlesworth, G D Smith, A M MacNicol.   

Abstract

The maturation of human oocytes occurs in the absence of gene transcription. In model organisms, such as Drosophila, Xenopus, and the mouse, oocyte maturation and early pattern formation is mediated through the regulated translation of maternally derived mRNAs. The maturation-dependent stimulation of maternal mRNA translation is correlated with increases in poly(A) tail length, controlled through a process termed cytoplasmic polyadenylation. However, this mechanism of mRNA translational control has not been characterized in humans. In this study we report the cloning of a human cytoplasmic polyadenylation element binding (hCPEB) protein with sequence-specific RNA binding activity. Our data demonstrate that alternative splicing generates hCPEB mRNAs that encode proteins with a conserved C-terminal RNA binding domain but with different N-terminal regulatory domains. The hCPEB mRNA is expressed in the brain and heart as well as in immature oocytes, consistent with the hypothesis that cytoplasmic polyadenylation may regulate the translation of human mRNAs in both oocytes and somatic cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223249     DOI: 10.1016/s0378-1119(00)00588-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  12 in total

1.  A novel regulatory element determines the timing of Mos mRNA translation during Xenopus oocyte maturation.

Authors:  Amanda Charlesworth; John A Ridge; Leslie A King; Melanie C MacNicol; Angus M MacNicol
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

2.  The active form of Xp54 RNA helicase in translational repression is an RNA-mediated oligomer.

Authors:  Nicola Minshall; Nancy Standart
Journal:  Nucleic Acids Res       Date:  2004-02-24       Impact factor: 16.971

3.  Nucleocytoplasmic traffic of CPEB1 and accumulation in Crm1 nucleolar bodies.

Authors:  Michèle Ernoult-Lange; Ania Wilczynska; Maryannick Harper; Christelle Aigueperse; François Dautry; Michel Kress; Dominique Weil
Journal:  Mol Biol Cell       Date:  2008-10-15       Impact factor: 4.138

4.  Role of cdc2 kinase phosphorylation and conserved N-terminal proteolysis motifs in cytoplasmic polyadenylation-element-binding protein (CPEB) complex dissociation and degradation.

Authors:  George Thom; Nicola Minshall; Anna Git; Joanna Argasinska; Nancy Standart
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

5.  A conserved role of a DEAD box helicase in mRNA masking.

Authors:  N Minshall; G Thom; N Standart
Journal:  RNA       Date:  2001-12       Impact factor: 4.942

6.  Cytoplasmic polyadenylation element (CPE)- and CPE-binding protein (CPEB)-independent mechanisms regulate early class maternal mRNA translational activation in Xenopus oocytes.

Authors:  Amanda Charlesworth; Linda L Cox; Angus M MacNicol
Journal:  J Biol Chem       Date:  2004-01-29       Impact factor: 5.157

7.  Mos 3' UTR regulatory differences underlie species-specific temporal patterns of Mos mRNA cytoplasmic polyadenylation and translational recruitment during oocyte maturation.

Authors:  C Krishna Prasad; Mahendran Mahadevan; Melanie C MacNicol; Angus M MacNicol
Journal:  Mol Reprod Dev       Date:  2008-08       Impact factor: 2.609

8.  Comparative in silico analyses of cpeb1-4 with functional predictions.

Authors:  Xiang-Ping Wang; Nigel G F Cooper
Journal:  Bioinform Biol Insights       Date:  2010-08-30

Review 9.  Functional Integration of mRNA Translational Control Programs.

Authors:  Melanie C MacNicol; Chad E Cragle; Karthik Arumugam; Bruno Fosso; Graziano Pesole; Angus M MacNicol
Journal:  Biomolecules       Date:  2015-07-21

10.  CPEB1 modulates differentiation of glioma stem cells via downregulation of HES1 and SIRT1 expression.

Authors:  Jinlong Yin; Gunwoo Park; Jeong Eun Lee; Ju Young Park; Tae-Hoon Kim; Youn-Jae Kim; Seung-Hoon Lee; Heon Yoo; Jong Heon Kim; Jong Bae Park
Journal:  Oncotarget       Date:  2014-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.